Suchergebnisse - "Mano, Max S."

PubPharm (72)

1

More on treatment de-escalation, biomarkers of response in human epidermal growth factor receptor 2 (HER2)-positive breast cancer : long-term outcomes and translational research findings of the PREDIX HER2 trial

enthalten in: Annals of translational medicine | 2024

von Mano, M.

CommentOn: Clin Cancer Res. 2023 Feb 1;29(3):532-540. - PMID 36449695

2

Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate

enthalten in: Clinical drug investigation | 2023

von Fein, L. | Lazaretti, N. | Chuken, Y. | +9

ErratumIn: Clin Drug Investig. 2023 Sep 11;:. - PMID 37695417

3

Correction : Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate

enthalten in: Clinical drug investigation | 2023

von Fein, L. | Lazaretti, N. | Chuken, Y. | +9

ErratumFor: Clin Drug Investig. 2023 Sep;43(9):699-706. - PMID 37594640

4

Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate

enthalten in: Clinical drug investigation | 2023

von Fein, L. | Lazaretti, N. | Chuken, Y. | +9

5

Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate

enthalten in: Clinical drug investigation | 2023

von Fein, L. | Lazaretti, N. | Chuken, Y. | +9

6

Reply to R. Freitas-Junior et al

enthalten in: JCO global oncology | 2023

von Resende, C. | Dienstmann, R. | Mano, M.

7

Results of a survey study on health professionals' perceptions of tumor boards in Brazil

enthalten in: Future oncology (London, England) | 2023

von Menezes, T. | Serra, M. | Barrios, C. | +7

8

Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Denkert, C. | Lambertini, C. | Fasching, P. | +15

9

If you can't kill the beast, tame it : Tips for surviving WhatsApp® in medical practice

enthalten in: Clinics (Sao Paulo, Brazil) | 2023

von Mano, M.

10

Impact of the COVID-19 Pandemic on Cancer Staging : An Analysis of Patients With Breast Cancer From a Community Practice in Brazil

enthalten in: JCO global oncology | 2022

von Resende, C. | Fernandes Cruz, H. | Costa E Silva, M. | +15

CommentIn: JCO Glob Oncol. 2023 Jun;9:e2300108. - PMID 37428993

1
2
3
4
5
6
7
8
Nächster »
[8]